粘菌素
多粘菌素
生物发生
表型筛选
小分子
脂质A
作用机理
抗生素
脂多糖
化学
计算生物学
生物
对接(动物)
行动方式
酶
药物发现
表型
机制(生物学)
药理学
细菌
抗生素耐药性
高通量筛选
药物开发
微生物学
生物化学
虚拟筛选
多粘菌素B
作者
Rho-Eun Lee,Jihyeon Kim,Chaeyoung Lee,Inseo Kim,Hyungjin Eoh,Wonsik Lee
标识
DOI:10.1021/acsinfecdis.5c00960
摘要
Multidrug-resistant (MDR) Acinetobacter baumannii is a major clinical threat with limited treatment options, as current therapies rely on polymyxins such as colistin. Targeting the lipopolysaccharide (LPS) biosynthetic pathway offers a new target for new antibiotic discovery, yet most efforts have focused on enzyme-based assays that do not reflect cell level physiology. Here, we developed a cell-based screening strategy that links colistin resistance to inhibition of lipooligosaccharide (LOS) biogenesis in A. baumannii . Using colistin, we established a phenotypic platform in which compounds that inhibit LOS synthesis rescue bacterial growth from colistin’s mode of action. This approach allows direct identification of inhibitors acting on essential LPS enzymes, including LpxC. Screening a library of about 7000 small molecules discovered non-hydroxamate compounds that restored growth under colistin stress. Hit compounds were validated through LpxC enzyme assays and protein-compound binding assays. Furthermore, our molecular docking study suggests that the hit compounds bind to the LpxC catalytic pocket similarly to CHIR-090. Together, our work introduces a novel phenotypic screening strategy for discovering LPS targeted inhibitors and provides new chemical scaffolds for developing antibiotics against A. baumannii and other Gram-negative pathogens.
科研通智能强力驱动
Strongly Powered by AbleSci AI